PEH Blog

Tag: intellectual property

  • Has the Indian Patents Act succeeded in ensuring access to affordable medicine?

    —

    posted by

    David Legge
    in
    David Legge Avatar

    Prof Biswajit Dhar (in The Leaflet, 16 April 2025) argues that the major flexibilities in the Indian Patent Act – Section 3(d) and the compulsory licensing system – to make medicines affordable, have been under-implemented. As prices of medicines have skyrocketed, secondary patenting has proliferated while compulsory licensing has been invoked only once. In full…

  • Gilead’s short-term win threatens the future of pharmaceutical public-private partnerships

    —

    posted by

    David Legge
    in
    David Legge Avatar

    Opinion by Christopher Morten et al in STAT News 12 Deb 2025 On Dec. 19, 2024, we joined other professors of law, medicine, and public health to file an amicus brief in support of the U.S. government in the government’s landmark patent lawsuit against leading HIV drugmaker Gilead Sciences Inc. On Jan. 15, 2025, the U.S. government…

  • Trade disputes over IP and health

    —

    posted by

    David Legge
    in
    David Legge Avatar

    Thanks to KEI for sharing the following references on trade related bullying. Time-line of Disputes over Compulsory Licensing  and Parallel Importation in South Africa, 1994 to 1999. http://www.cptech.org/ip/health/sa/sa-timeline.txt Susannah Markandya, Timeline of Trade Disputes involving Thailand and access to medicines, July 23, 2001   (Timeline entries from 1979 to 2001). http://www.cptech.org/ip/health/c/thailand/thailand.html Susannah Markandya, Timeline of disputes…